Daliresp 500 MCG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FM37B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,607
Award facts
- Contract value 100% obligated
- $22,607.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22.6K delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Daliresp 500 micrograms. This non-set-aside, firm fixed-price contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Daliresp is a phosphodiesterase-4 inhibitor used in the treatment of chronic obstructive pulmonary disease, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), valued at $999.99M through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen operates as a subsidiary of Cencora, Inc., which itself holds a parallel $999.99M IDC with DLA Troop Support Medical extending through December 2031. These comprehensive contract vehicles enable AmerisourceBergen to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM37B?
SPE2DR26FM37B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FM37B worth?
The government has obligated $22,607 on SPE2DR26FM37B.
Is contract SPE2DR26FM37B an order under another contract?
Yes. SPE2DR26FM37B is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM37B competed?
The extent of competition for SPE2DR26FM37B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award